Pyrophosphorylated-Cholesterol-Modified Bone-Targeting Liposome Formulation Procedure

Pharmacology, Toxicology and Pharmaceutical Science

• Fracture Nonunion 100%
• Liposome Targeting 100%
• Drug Delivery System 66%
• Pharmacotherapy 33%
• Bisphosphonic Acid Derivative 33%
• Hydroxyapatite 33%
• Pyrophosphate 33%
• Tetracycline Derivative 33%
• Liposome 33%
• Polyanion 33%
• Musculoskeletal Disease 33%
• Bone Disease 33%
• Anabolic Steroid 33%
• Fracture 33%

Keyphrases

• Hydrophilic Drug Encapsulation 12%
• Modified Liposome 12%
• Cholesterol Ligand 12%